Soft-tissue Sarcoma Clinical Trial
Official title:
A Phase Ib Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma
A phase Ib study of Olaparib with concomitant radiotherapy in locally advanced/unresectable soft-tissue sarcoma.
This is a multicenter, prospective phase Ib trial based on a dose escalation study design (3+3 traditional design) assessing four dose levels of Olaparib given with concomitant radiotherapy, followed by an expansion cohort. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
| Recruiting |
NCT02630368 -
A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)
|
Phase 1/Phase 2 | |
| Completed |
NCT01438554 -
Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma
|
Phase 1 | |
| Active, not recruiting |
NCT03602833 -
Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03475953 -
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03242382 -
Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.
|
Phase 2 | |
| Recruiting |
NCT04181970 -
Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK
|
||
| Completed |
NCT01389050 -
High Precision RT For Soft-Tissue Sarcoma
|
Phase 2 | |
| Recruiting |
NCT03096912 -
A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma
|
Phase 2 | |
| Terminated |
NCT02987959 -
Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas
|
Phase 2 | |
| Recruiting |
NCT03175718 -
INPWT on Wound Complications & Clinical Outcomes After Lower Extremity Sarcoma Surgery Preop Radiation Therapy Patients
|
N/A | |
| Recruiting |
NCT05741944 -
The Value of a Risk Prediction Tool (PERSARC) for Effective Treatment Decisions of Soft-tissue Sarcomas Patients
|
N/A | |
| Active, not recruiting |
NCT03016819 -
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
|
Phase 3 |